Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.6.5 was added to the record history and the prior v3.6.4 entry was removed, indicating an update to the study's version history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision (v3.6.4) has been added to the Study Record History, replacing the previous revision (v3.6.3). This reflects an updated version of the record.SummaryDifference0.1%

- Check46 days agoChange DetectedThe study record history now shows a new revision entry labeled v3.6.3, indicating the record has been updated to a newer saved version.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision history now shows a new entry for v3.6.2 and removes the v3.6.0 entry, updating the page's version log. This reflects internal version control for the page and does not alter the study data or status.SummaryDifference0.1%

- Check67 days agoChange DetectedThe study page now shows that recruitment is no longer open to participants, clarifying that enrollment has ended. The record history reflects a new revision (v3.6.0) replacing the previous v3.5.5.SummaryDifference0.4%

- Check75 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, replacing the previous revision (v3.5.4), reflecting an update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.